Arena Pharmaceuticals (ARNA)

$62.89 0.85 (1.33%)

16:00 EDT ARNA Stock Quote Delayed 30 Minutes

7 Busted Biotech Stocks Due for a Rebound

By Chris Lau, InvestorPlace Contributor Sep 8, 2021

Buying biotech stocks while they're down is rewarding once they post positive clinical results, setting the stage for a big rally.

8 Biotech Stocks to Watch After the Q2 Earnings Season

5 Clinical-Stage Biotech Stocks to Buy

Don’t Get Trapped by All the Hype Surrounding Cronos Stock

Volume:

Previous Close -

Market Cap 3.84B

PE Ratio -7.70

EPS -8.17

Volume (Avg. Vol.) 392,197

Day's Range 62.26 - 64.90

52-Week Range 45.50 - 90.19

Dividend & Yield N/A (N/A)

ARNA Stock Predictions, Articles, and Arena Pharmaceuticals News

From InvestorPlace
From the Web

6 Stocks Set for Monster Growth in 2019

By Harriet Lefton, Writer, TipRanks Jan 28, 2019

Looking for stocks to buy now? These six companies are among the best stocks to invest in for their immaculate record from the Street's top analysts. Here's why:

Why Arena Pharmaceuticals Stock Is Soaring Today

By William White, InvestorPlace Writer Nov 15, 2018

Arena Pharmaceuticals stock was soaring Thursday on news of a license deal with United Therapeutics (UTHR) for ralinepag.

Intercept Pharmaceuticals Inc (ICPT) Stock Dives on Drug Warning

By William White, InvestorPlace Writer Sep 12, 2017

Intercept Pharmaceuticals (ICPT) stock took a hit on Tuesday following the release of a drug warning concerning its Ocaliva.

3 Stocks to Watch on Tuesday: Snap Inc (SNAP), Barracuda Networks Inc (CUDA) and Arena Pharmaceuticals, Inc. (ARNA)

By Karl Utermohlen, InvestorPlace Writer Jul 11, 2017

Snap (SNAP) continues slumping below its IPO price Tuesday and Arena Pharmaceuticals (ARNA) rockets ahead on trial data, while Barracuda Networks (CUDA) slides on earnings.

5 Reasons Why VIVUS, Inc. (VVUS) Stock Should Be in Your Portfolio

By Zacks Investment Research May 25, 2017

VIVUS is a biopharmaceutical company developing and commercializing innovative, next-generation therapies. Here's why VVUS stock is a must

3 Stocks to Watch on Wednesday: Bank of America Corp (BAC), Arena Pharmaceuticals, Inc. (ARNA) and Fogo De Chao Inc (FOGO)

By Karl Utermohlen, InvestorPlace Writer Mar 15, 2017

Bank of America (BAC) anxiously awaits a Fed decision on Wednesday, Arena Pharmaceuticals (ARNA) rockets higher and Fogo de Chao (FOGO) carves out some gains.

26 Biotechnology Stocks to Sell Now

By Portfolio Grader Sep 19, 2016

The ratings of 26 Biotechnology stocks are down this week, according to the Portfolio Grader database. Each of these rates a "D" ("sell") or "F" overall ("strong sell").

23 Biotechnology Stocks to Sell Now

By Portfolio Grader Sep 12, 2016

The overall ratings of 23 Biotechnology stocks are down on Portfolio Grader this week. Each of these rates a "D" ("sell") or "F" overall ("strong sell").

22 Biotechnology Stocks to Sell Now

By Portfolio Grader Jul 11, 2016

This week, 22 Biotechnology stocks are worse, according to the Portfolio Graderdatabase. Each of these rates a "D" ("sell") or "F" overall ("strong sell").

19 Biotechnology Stocks to Sell Now

By Portfolio Grader Jul 4, 2016

The overall ratings of 19 Biotechnology stocks are down on Portfolio Grader this week. Each of these rates a "D" ("sell") or "F" overall ("strong sell").

3 Stocks to Watch on Friday: Arena Pharmaceuticals, Inc. (ARNA), Micron Technology, Inc. (MU) and Tesla Motors Inc (TSLA)

By Karl Utermohlen, InvestorPlace Writer Jul 1, 2016

Tesla (TSLA) shares fell on a self-driving accident, Arena Pharmaceuticals (ARNA) will cut more than half its workforce and Micron (MU) misses revenue estimates.